New antibiotic guidelines could save more lives in intensive care units

More lives could be saved in intensive care units around the world if new antibiotic guidelines designed by The University of Queensland are adopted.

Researchers have launched universal Therapeutic Drug Monitoring (TDM) guidelines to optimize the concentrations of antibiotic and antifungal medications given to severely ill patients in hospital.

UQ Centre for Clinical Research Professor Jason Roberts said the guidelines could speed up recovery times or even save a critically ill patient from dying.

There's significant variation around the world on how to treat serious infections, and sometimes it's a bit of a guessing game.

All patients in ICU are currently treated with similar antibiotics and doses, but the lack of personalization can make a patient sicker and may even cause death.

Overuse or underuse of antibiotics can enable resistance of bacteria in the patient which limits the drug's effectiveness."

Professor Jason Roberts, UQ Centre for Clinical Research

UQ CCR Pharmacist Dr. Hafiz Abdul-Aziz worked with a team of experts to analyze data from 400 ICU patients and found one-third experienced adverse outcomes because their antibiotic therapy wasn't optimized to their needs.

"We found a patient's response to the antibiotic improved significantly if the dosage was monitored and altered accordingly," Dr Abdul-Aziz said.

The innovative guidelines were developed by 16 antibiotic experts from 11 different countries and recommended the use of advanced software to predict accurate drug dosages and generate personalized treatment regimens.

Dr. Abdul-Aziz said more than 160,000 Australians required specialized care in ICU and 13 per cent of these patients died each year.

ICU patients requiring antibiotics commonly suffer vital organ failure from sepsis, pneumonia or infections from burns.

Dr. Abdul-Aziz said monitoring equipment and training needed to be rolled-out before routine TDM can be adopted as the worldwide standard-of-care.

Journal reference:

Abdul-Aziz, M.H., et al. (2020) Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper. Intensive Care Medicine.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
You might also like...
Clovibactin - a game-changing novel antibiotic with no resistance